Asian shares gain as investors shift focus to Federal Reserve, tariffs
BANGKOK (AP) — Asian shares have logged modest gains after U.S. stocks climbed to near their all-time high as investors considered comments by Federal Reserve Chair Jerome Powell to Congress.
Oil prices gained more than 1% early Wednesday after falling about 6% on Tuesday on hopes that Israel's war with Iran will not hinder the global flow of crude. Lower oil prices could give the Federal Reserve leeway to cut interest rates to help the economy, and Powell said it is waiting for the right time to do so.
The fragile ceasefire between Iran and Israel, announced by Trump a day earlier, appeared to be holding after initially faltering.
U.S. benchmark crude gained 1.2% to $65.16 per barrel, while Brent crude, the international standard, climbed 1.1% to $66.95.
Lower oil prices could give the Federal Reserve leeway to cut interest rates to help the economy, and Powell said it will continue to wait and see how the economy evolves before deciding whether to reduce its key interest rate, a stance directly at odds with President Donald Trump's calls for immediate cuts.
'For the time being, we are well positioned to wait to learn more about the likely course of the economy before considering any adjustments to our policy stance,' Powell said in testimony Tuesday before the House Financial Services Committee.
In Asian trading early Wednesday, Tokyo's Nikkei 225 picked up 0.3% to 38,917.08 and the Hang Seng in Hong Kong advanced 0.9% to 24,386.59.
The Shanghai Composite index rose 0.5% to 3,437.10.
In South Korea, the Kospi edged 0.2% higher to 3,110.19, while Australia's S&P/ASX 200 added 0.1% to 8,562.90.
Taiwan's Taiex gained 1.1% and the Sensex in India was up 0.7%. In Bangkok, the SET slipped 0.4%.
'The world can now move on to face other difficult choices like tariffs and things like that. So I think the market is well on its way to rebound and could again reach new levels,' said Frances Lun, CEO of GEO Securities in Hong Kong.
On Tuesday, the S&P 500 climbed 1.1% to 6,092.18, following up on big gains for stocks across Europe and Asia, after President Donald Trump said late Monday that Israel and Iran had agreed to a 'complete and total ceasefire.' The main measure of Wall Street's health is back within 0.8% of its record set in February after falling roughly 20% below during the spring.
The Dow Jones Industrial Average jumped 1.2% to 43,089.02, and the Nasdaq composite rallied 1.4% to 19,912.53.
The fear throughout the Israel-Iran conflict has been that it could squeeze the world's supply of oil, which would pump up prices for gasoline and hurt the global economy. Iran is a major producer of crude, and it could also try to block the Strait of Hormuz off its coast, through which 20% of the world's daily oil needs passes on ships.
Now, oil prices have dropped so much in the last two days that they're below where they were before the fighting began nearly two weeks ago.
With the global oil market well supplied and the OPEC+ alliance of producing countries steadily increasing production, oil prices could be headed even lower as long as the ceasefire holds and a lasting peace solution can be found.
Monday Mornings
The latest local business news and a lookahead to the coming week.
'Easing stress in energy markets is excellent news for everyone who doesn't want to see higher oil prices translating into accelerating inflation and tighter monetary policy. So the market mood is restored,' Ipek Ozkardeskaya, a senior analyst with Swissquote Bank, said in a commentary.
The Fed has said repeatedly that it wants to wait and see how much higher tariffs imposed by Trump will hurt the economy and raise inflation before committing to its next move. So far, the economy seems to be holding up OK, though a report on confidence among U.S. consumers came in weaker than economists expected on Tuesday, and inflation has remained only a bit above the Fed's 2% target.
In currency dealings, the U.S. dollar rose to 145.10 Japanese yen from 144.93 yen. The euro climbed to $1.1617 from $1.1610.
___
Video journalist Alice Feng in Hong Kong and AP Business Writer Stan Choe in New York contributed.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Globe and Mail
37 minutes ago
- Globe and Mail
Trade clarity to help Canada's economy rebound after modest recession, Deloitte forecasts
Some economists are putting an increasingly optimistic slant on Canada's tariff dispute with the United States, arguing the economy should be able to avoid 'worst-case' scenarios from the trade war. That doesn't mean the Canadian economy gets off scot-free – a new forecast published by Deloitte Canada on Wednesday calls for a modest recession to hit in the second and third quarters of the year as uncertainty and weakness caused by tariffs start to bite. 'We do think the economy really is going to be considerably slower,' said Dawn Desjardins, chief economist at Deloitte Canada. After a surprisingly strong first quarter that saw many businesses rush their orders to get ahead of looming tariffs, Canadian exports were already showing signs of a steep decline in April. Weakness in the manufacturing side of the labour market is expected to broaden in the months ahead, Deloitte Canada said. The unemployment rate is forecast to rise to 7.3 per cent by the fall from May's level of seven per cent. But Desjardins said this downturn could be much worse if Canada hadn't secured tariff exemptions for CUSMA-compliant exports in early negotiations with the United States. Inflation holds steady at 1.7% as underlying price pressures ease U.S. President Donald Trump's move to double steel and aluminum tariffs to 50 per cent earlier this month means those sectors are still set to take steeper hits, she said, particularly if Canada levies more reciprocal tariffs at the end of a 30-day negotiation deadline in July. Deloitte said parts of eastern and Central Canada, as well as British Columbia, will see subdued growth this year from the tariff dispute while the prairie provinces and Newfoundland and Labrador will see their output rise, thanks largely to energy exports. Overall, Desjardins said the status quo – if maintained – does not mark the 'worst-case outcome' for Canada's economy that some might have feared a few months ago when tariff talks were ramping up. Deloitte expects that, even with two negative quarters, Canada will post real GDP growth of 1.1 per cent this year. That would accelerate to 1.6 per cent in 2026 – not headline shattering growth by any means, but better than a protracted downturn. Unemployment would also drop back below seven per cent early next year, the report said. Deloitte is not the only one bringing a bit of optimism to the forecast. RBC published a report June 13 that also focuses on Canada's upside risks – economist shorthand for ways things might turn out for the better – amid what it called a 'gloomy' outlook on the trade war to date. 'While Canada's economic path forward remains challenging, it appears considerably less treacherous than it did just a few months ago – a narrative that has yet to permeate the Canadian psyche,' the RBC report read. Canada to limit foreign steel imports to help producers hit by U.S. tariffs Consumer and business confidence has taken a hit as Canadians wait for an outcome from trade negotiations with the United States, but RBC noted the hard data so far shows households are still spending despite the uncertainty. Desjardins also believes that once businesses get a bit more clarity on the trade front – talks so far appear productive, she said – they will also have the confidence to pick up investment again. She projects that will set up an economic recovery starting in the second half of the year, fuelled in part by a pair of additional quarter-point rate cuts from the Bank of Canada in the coming months. RBC, on the other hand, believes the economy is showing enough life that it doesn't need any support from additional rate cuts this year. That could change if cracks start to form in the economy, but RBC's assistant chief economist Nathan Janzen said he expects the central bank will remain on hold given 'resilience' in the economy. 'There is still room for the Bank of Canada to respond with more monetary policy support if the economy needs it,' he said. Both RBC and Deloitte point to recent steps taken by the federal government as girding Canada's economy from a steeper economic downturn. Canada, U.S. exchanging potential terms on economic and security deal The House of Commons passed Bill C-5 at the end of last week, a sweeping set of legislation that aims to reduce interprovincial trade barriers and speed up major project development. Desjardins said the bill helps address long-standing reputational issues that Canadian industry is slow-moving and gets mired in red tape before getting shovels into the ground. While economists have long been banging the drum to draw attention to Canada's weak business investment levels and flagging productivity, she said the 'jolt' of the trade war has finally 'brought this to the top of this agenda.' 'This signals to business that Canada is now ready to move to a stronger playing field,' she said. RBC agreed that 'action on interprovincial trade barriers could pay long-run dividends helping to support investment and productivity growth.' Uncertainty about the U.S. market in the global trade upheaval also offers an opportunity for resource-rich Canada to support growing worldwide demand for critical minerals necessary to power artificial intelligence and defence products, RBC said. Desjardins said it could be years before today's steps to knock down interprovincial trade barriers and build out national infrastructure pay dividends. It takes time to reorient supply chains, and manufacturing industries in some provinces will still take a hit during the adjustment. But she argued that the signal is nearly as important as the outcome when it comes to giving businesses the confidence they need to invest. Adopting this 'One Canadian Economy' framework, as Ottawa has dubbed it, 'is not a magic wand that changes the landscape,' Desjardins said. 'It is building more resilience in the economy and more room for growth.'
Globe and Mail
an hour ago
- Globe and Mail
3 Reasons to Buy Eli Lilly Stock Like There's No Tomorrow
Eli Lilly (NYSE: LLY) has been on fire over the past two years. The drugmaker has generated excellent financial results and delivered strong market performance -- so strong that detractors might think it's too late to invest. Lilly's forward price-to-earnings (P/E) ratio currently tops 35, which is more than twice the average of 15.8 for the healthcare industry. And that's before we get into other issues, such as President Donald Trump's tariff policies, which could harm Lilly's financial results. Even with these potential headwinds, though, there are excellent reasons to invest in Eli Lilly. Let's consider three of them. Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Continue » 1. Taking the lead in the weight loss market Eli Lilly has been a leader in the diabetes drug market for decades. That business is still performing well, and over the past five years, the pharmaceutical giant has also made significant clinical and regulatory progress in the related anti-obesity space. It earned approval for Mounjaro and Zepbound, which treat obesity and diabetes (respectively) and are already generating well over $1 billion per quarter. Lilly recently posted phase 3 results for orforglipron. This investigational oral GLP-1 medicine would provide patients with another option, as the current leading medications are administered by subcutaneous injection. The pipeline also features retatrutide, a triple agonist that posted strong phase 2 results. More recently, Lilly reported encouraging phase 1 data for a next-gen weight loss medicine. The company has been even more impressive than Novo Nordisk, its longtime rival, from which it has arguably taken the lead. While Novo Nordisk was first to market with medicines like Ozempic and Wegovy, the Denmark-based company faced some clinical setbacks. Meanwhile, Lilly is notching win after win. Eli Lilly's position in the weight management market makes its stock attractive, considering how fast this area is projected to grow in the coming years. 2. Diversifying its lineup and pipeline Eli Lilly isn't a one-trick pony. The company's lineup of approved medicines features blockbusters like Verzenio, a cancer drug, and Taltz, an immunosuppressant. It also includes likely future blockbusters such as Alzheimer's disease treatment Kisunla and eczema treatment Ebglyss. Lilly isn't slowing down, though. The company has been expanding its pipeline through acquisitions. In May, it acquired SiteOne Therapeutics, a small biotech with a promising oral non-opioid pain inhibitor in clinical trials. Though there are plenty of pain treatments, there is a need for non-opioid options, given the potential side effects of opioid-based therapies. The buyout of SiteOne Therapeutics cost Eli Lilly $1 billion in cash. Then on June 17, Lilly announced it would acquire Verve Therapeutics, a biotech that develops gene-editing medicines for cardiovascular diseases, for about $1.3 billion in cash. These deals demonstrate that Eli Lilly doesn't want to rely too heavily on its core therapeutic areas, which investors should appreciate. 3. Justifying its valuation with its outlook Eli Lilly's valuation might be a significant stumbling block for some investors. If the stock fails to meet the market's lofty expectations, its shares will plummet. That's what happened after the company reported first-quarter earnings. Though they would have been considered blowout results for any other pharmaceutical giant of comparable size, Eli Lilly is different. Weaker-than-expected guidance sent the stock price down significantly. Even so, Lilly grew revenue by 45% year over year to $12.7 billion. Revenue growth in this range is exceedingly rare for a drugmaker of this size. And net income grew by a still-impressive 29% year over year to $3 billion. Eli Lilly is worth a premium considering the strength of its financial results, even if the stock is somewhat volatile in the short term. The company's work in weight management, diabetes, and other areas should lead to numerous clinical and regulatory successes over the next five years, as well as consistently above-average growth on the top and bottom lines. That's why despite its rich valuation metrics, the stock remains a buy. Should you invest $1,000 in Eli Lilly right now? Before you buy stock in Eli Lilly, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Eli Lilly wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $676,023!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $883,692!* Now, it's worth noting Stock Advisor 's total average return is793% — a market-crushing outperformance compared to173%for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of June 23, 2025
Globe and Mail
2 hours ago
- Globe and Mail
World shares are mixed as a fragile Israel-Iran ceasefire holds
BANGKOK (AP) — European shares slipped and Asian benchmarks advanced on Wednesday as a fragile truce between Israel and Iran appeared to be holding. Oil prices rebounded slightly after falling about 6% on Tuesday on hopes that the brief war will not hinder the global flow of crude. U.S. benchmark crude gained 1.3% to $65.20 per barrel, while Brent crude, the international standard, climbed 1.1% to $66.92. Lower oil prices could give the Federal Reserve leeway to cut interest rates to help the U.S. economy. Its chair, Jerome Powell, said Tuesday the central bank is waiting to see how the economy evolves before deciding whether to reduce its key interest rate, a stance directly at odds with President Donald Trump's calls for immediate cuts. 'For the time being, we are well positioned to wait to learn more about the likely course of the economy before considering any adjustments to our policy stance,' Powell said in testimony Tuesday before the House Financial Services Committee. In early European share trading, Germany's DAX fell 0.4%, giving up early gains, to 23,540.08 and the CAC 40 in Paris shed 0.2% to 7,603.30. Britain's FTSE 100 was flat at 8,758.48, while U.S. futures were little changed. Shares advanced in Asia, where Tokyo's Nikkei 225 picked up 0.4% to 38,942.07. The Hang Seng in Hong Kong advanced 1.2% to 24,474.67 and the Shanghai Composite index jumped 1% to 3,455.97. 'The world can now move on to face other difficult choices like tariffs and things like that. So I think the market is well on its way to rebound and could again reach new levels,' said Frances Lun, CEO of GEO Securities in Hong Kong. In South Korea, the Kospi edged less than 0.1% higher to 3,108.25, while Australia's S&P/ASX 200 also was barely changed, at 8,559.20. Taiwan's Taiex gained 1.1% and the Sensex in India was up 0.8%. In Bangkok, the SET added 0.3% after the Thai central bank opted to keep its key interest rate unchanged. On Tuesday, the S&P 500 climbed 1.1%, following up on big gains for stocks across Europe and Asia, after Trump said late Monday that Israel and Iran had agreed to a 'complete and total ceasefire.' The main measure of Wall Street's health is back within 0.8% of its record set in February after falling roughly 20% below during the spring. The Dow Jones Industrial Average jumped 1.2% and the Nasdaq composite rallied 1.4%. The fear throughout the Israel-Iran conflict has been that it could squeeze the world's supply of oil, which would pump up prices for gasoline and hurt the global economy. Iran is a major producer of crude, and it could also try to block the Strait of Hormuz off its coast, through which 20% of the world's daily oil needs passes on ships. Now, oil prices have dropped so much in the last two days that they're near where they were before the fighting began nearly two weeks ago. With the global oil market well supplied and the OPEC+ alliance of producing countries steadily increasing production, oil prices could be headed even lower as long as the ceasefire holds and a lasting peace solution can be found. 'Easing stress in energy markets is excellent news for everyone who doesn't want to see higher oil prices translating into accelerating inflation and tighter monetary policy. So the market mood is restored,' Ipek Ozkardeskaya, a senior analyst with Swissquote Bank, said in a commentary. The Fed has said repeatedly that it wants to wait and see how much higher tariffs imposed by Trump will hurt the U.S. economy and raise inflation before committing to its next move. So far, the economy seems to be holding up OK, though a report on confidence among U.S. consumers came in weaker than economists expected on Tuesday, and inflation has remained only a bit above the Fed's 2% target. In currency dealings, the U.S. dollar rose to 145.64 Japanese yen from 144.93 yen. The euro climbed to $1.1600 from $1.1610.
